China-based Sanyou Biopharmaceuticals and NovoCodex Biopharmaceuticals have jointly announced that the two companies hav...
Novo Nordisk has announced that Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly i...
The latest personalised mRNA cancer vaccine data have renewed attention on individualized oncology. How significant is t...
Boomray Pharmaceuticals, a China-based clinical-stage biotechnology company pioneering innovative radioligand therapies ...
Australia-based Telix Pharmaceuticals has signed a strategic agreement to lead a merger with ITM Isotope Technologies Mu...
South Korea-based 1ST Biotherapeutics, Inc. and SK Biopharmaceuticals have entered into an exclusive global li...
Swiss pharma firm Roche has announced the grand opening of the Roche Genentech Innovation Center Boston, expanding Roche...
India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity sharehol...
Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy&...
Eisai Co. and Biogen Inc. have announced that LEQEMBI® Pen, the subcutaneous (SC) formulation of the anti-amyloid be...
Ask anyone who negotiates drug licences for a living what changed in the last two years, and you will usually get the sa...
Shilpa Biologicals, an India-based integrated biologics development and manufacturing organisation, has announced an exc...
The Ministry of Health and Welfare (MOHW), South Korea government, has announced the launch of the Public-Private Pharma...
GSK plc has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) from Chimagen Bio...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pe...
BioSpectrum Asia has published The CEO Handbook 2026, a seventy two page Career Spotlight edition profiling fifty chief ...
Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia f...
ENA Respiratory, a clinical-stage pharmaceutical startup developing host defence enhancers for the prevention of complic...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Singapore is expanding subsidised access to Roche’s Columvi, or glofitamab, for eligible patients with relapsed or...
Before we discuss the market, can you tell us about your role and what drew you to this area of healthcare logistics? I...
For years, sustainability in pharmaceuticals was largely discussed in terms of commitments, targets and disclosures. Tha...
